Highlights
1. CD16+ γδ T cells exhibit potent antibody-dependent cellular cytotoxicity (ADCC) against HBV, inversely correlating with viral replication markers like HBcrAg.
2. Vδ2+ γδ T cells express activating receptor CD226, enhancing ADCC, while Vδ1+ cells show inhibitory TIGIT expression, suggesting a regulatory balance.
